Oltef-D Eye/Ear Drops contain a combination of Ofloxacin (0.3% w/v), a broad-spectrum fluoroquinolone antibiotic, and Dexamethasone (0.1% w/v), a potent corticosteroid. This formulation is indicated for the treatment of bacterial infections accompanied by inflammation in the eye or ear. Ofloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and promoting eradication of susceptible pathogens. Dexamethasone provides anti-inflammatory action by suppressing the release of inflammatory mediators, reducing swelling, redness, and discomfort associated with infections. Oltef-D is effective against a wide range of gram-positive and gram-negative bacteria, making it suitable for conditions such as bacterial conjunctivitis, keratitis, otitis externa, and otitis media with tympanostomy tubes. The combination therapy helps alleviate symptoms rapidly while addressing the underlying infection. Oltef-D Eye/Ear Drops should be used under medical supervision, with dosage and duration tailored to the specific clinical condition. Caution is advised in patients with viral or fungal infections, glaucoma, or hypersensitivity to any component. Proper administration technique and adherence to prescribed regimen are essential to optimize therapeutic outcomes and minimize potential adverse effects.